| Literature DB >> 31058006 |
Abstract
The goal of this review was to present the essential steps in the entire process of clinical research. Research should begin with an educated idea arising from a clinical practice issue. A research topic rooted in a clinical problem provides the motivation for the completion of the research and relevancy for affecting medical practice changes and improvements. The research idea is further informed through a systematic literature review, clarified into a conceptual framework, and defined into an answerable research question. Engagement with clinical experts, experienced researchers, relevant stakeholders of the research topic, and even patients can enhance the research question's relevance, feasibility, and efficiency. Clinical research can be completed in two major steps: study designing and study reporting. Three study designs should be planned in sequence and iterated until properly refined: theoretical design, data collection design, and statistical analysis design. The design of data collection could be further categorized into three facets: experimental or non-experimental, sampling or census, and time features of the variables to be studied. The ultimate aims of research reporting are to present findings succinctly and timely. Concise, explicit, and complete reporting are the guiding principles in clinical studies reporting.Entities:
Keywords: clinical epidemiology; conceptual framework; literature review; research question; study designs; study reporting
Year: 2019 PMID: 31058006 PMCID: PMC6476607 DOI: 10.7759/cureus.4112
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Overview of the essential concepts of the whole clinical research process
aFeasibility and efficiency are considered during the refinement of the research question and adhered to during data collection.
| Concept | Research Idea | Research Question | Acquiring Data | Analysis | Publication | Practice |
| Actions | Relevant clinical problem or issue | Primary or secondary | Measuring | Prespecified | Writing skills | Guidelines |
| Literature review | Quantitative or qualitative | Measuring tool | Predetermined | Guidelines | Protocol | |
| Conceptual framework | Causal or non-causal | Measurement | Exploratory allowed | Journal selection | Policy | |
| Collaboration with experts | Feasibilitya | Feasibilitya | Strength and direction of the effect estimate | Response to reviewers’ comments | Change | |
| Seek target population’s opinions on the research topic | Efficiencya | Efficiencya | ||||
| Theoretical Design | Data Collection Design | Statistical design | ||||
| Domain (external validity) | Experimental or non-experimental | Data cleaning | ||||
| Valid (confounding minimized) | Sampling or census | Outlier | ||||
| Precise (good sample size) | Time features | Missing data | ||||
| Pilot study | Descriptive | |||||
| Inferential | ||||||
| Statistical assumptions | ||||||
| Collaboration with statistician |
Figure 1Fundamental classification of clinical studies
Examples of clinical study titles according to the category of research and the data collection designs
| Research Category | Study Title |
| Diagnostic | Plasma Concentration of B-type Natriuretic Peptide (BNP) in the Diagnosis of Left Ventricular Dysfunction |
| The Centor and McIsaac Scores and the Group A Streptococcal Pharyngitis | |
| Prognostic | The Apgar Score and Infant Mortality |
| SCORE (Systematic COronary Risk Evaluation) for the Estimation of Ten-Year Risk of Fatal Cardiovascular Disease | |
| Intervention | Dexamethasone in Very Low Birth Weight Infants |
| Bariatric Surgery of Obesity in Type 2 Diabetes and Metabolic Syndrome | |
| Etiologic | Thalidomide and Reduction Deformities of the Limbs |
| Work Stress and Risk of Cardiovascular Mortality |
The PICOT and FINER of a research question
| Acronym | Explanation |
| P = | Patient (or the domain) |
| I = | Intervention or treatment (or the determinants in non-experimental) |
| C = | Comparison (only in experimental) |
| O = | Outcome |
| T = | Time describes the duration of data collection |
| F = | Feasible with the current and/or potential available resources |
| I = | Important and interesting to current clinical practice and to you, respectively |
| N = | Novel and adding to the existing corpus of scientific knowledge |
| E = | Ethical research conducted without harm to participants and institutions |
| R = | Relevant to as many parties as possible, not only to your own practice |
Figure 2The confounders in a causal relationship
Examples of clinical study titles according to the data collection designs
| Data Collection Designs | Study Title |
| Cross-sectional | The National Health and Morbidity Survey (NHMS) |
| The National Health and Nutrition Examination Survey (NHANES) | |
| Cohort | Framingham Heart Study |
| The Malaysian Cohort (TMC) project | |
| Case-control | A Case-Control Study of the Effectiveness of Bicycle Safety Helmets |
| Open-Angle Glaucoma and Ocular Hypertension: the Long Island Glaucoma Case-Control Study | |
| Nested case-control | Nurses' Health Study on Plasma Adipokines and Endometriosis Risk |
| Physicians' Health Study Plasma Homocysteine and Risk of Myocardial Infarction | |
| Randomized controlled trial | The Women’s Health Initiative |
| U.K. Prospective Diabetes Study | |
| Cross-over | Intranasal-agonist in Allergic Rhinitis Published in the Allergy in 2000 |
| Effect of Palm-based Tocotrienols and Tocopherol Mixture Supplementation on Platelet Aggregation in Subjects with Metabolic Syndrome |
The advantages and disadvantages of experimental and non-experimental data collection designs
aMay be an issue in cross-sectional studies that require a long recall to the past such as dietary patterns, antenatal events, and life experiences during childhood.
| Non-experimental | Experimental |
| Advantages | |
| Quick results are possible | Comparable groups |
| Relatively less costly | Hawthorne and placebo effects mitigated |
| No recall biasa | Straightforward, robust statistical analysis |
| No time effects | Convincing results as evidence |
| Real-life data | |
| Disadvantages | |
| Observed, unobserved, and residual confounding | Expensive |
| Time-consuming | |
| Overly controlled environment | |
| Loss to follow-up | |
| Random allocation of potentially harmful treatment may not be ethically permissible | |
Figure 3The time features of a variable
Figure 4Statistical tests available for analyses of different types of data
Examples of reporting guidelines and checklists
| No. | Reporting Guidelines and Checklists | |
| CONSORT - CONsolidated Standards Of Reporting Trials | ||
| A 25-item checklist for reporting of randomized controlled trials. There are appropriate extensions to the CONSORT statement due to variations in the standard trial methodology such as different design aspects (e.g., cluster, pragmatic, non-inferiority and equivalence trials), interventions (e.g., herbals) and data (e.g., harms, including the extension for writing abstracts) | ||
| SPIRIT - Standard Protocol Items: Recommendations for Interventional Trials | ||
| A 33-item checklist for reporting protocols for randomized controlled trials | ||
| COREQ - COnsolidated criteria for REporting Qualitative research | ||
| A 32-item checklist for reporting qualitative research of interviews and focus groups | ||
| STARD - STAndards for the Reporting of Diagnostic accuracy studies | ||
| A 25-item checklist for reporting of diagnostic accuracy studies | ||
| PRISMA - Preferred Reporting Items for Systematic reviews and Meta-Analyses | ||
| A 27-item checklist for reporting of systematic reviews | ||
| PRISMA-P - Preferred Reporting Items for Systematic reviews and Meta-Analyses Protocols | ||
| A 17-item checklist for reporting of systematic review and meta-analysis protocols | ||
| MOOSE - Meta-analysis Of Observational Studies in Epidemiology | ||
| A 35-item checklist for reporting of meta-analyses of observational studies | ||
| STROBE - STrengthening the Reporting of OBservational studies in Epidemiology | ||
| For reporting of observational studies in epidemiology | ||
| Checklist for cohort, case-control and cross-sectional studies (combined) | ||
| Checklist for cohort studies | ||
| Checklist for case-control studies | ||
| Checklist for cross-sectional studies | ||
| Extensions of the STROBE statement | ||
| STROME-ID - STrengthening the Reporting Of Molecular Epidemiology for Infectious Diseases | ||
| A 42-item checklist | ||
| STREGA - STrengthening the REporting of Genetic Associations | ||
| A 22-item checklist for reporting of gene-disease association studies | ||
| CHEERS - Consolidated Health Economic Evaluation Reporting Standards | ||
| A 24-item checklist for reporting of health economic evaluations | ||